Finnish research into ocular medication secures FDA funding for the first time
Research into ocular medication carried out in Finland has secured a significant 250 000 dollar funding from the US Food and Drug Administration, FDA, which oversees the use of drugs and drug approval. This is the first time the FDA grants funding to a Finnish project.A project led by Professor of Biopharmacy Arto Urtti at the University of Eastern Finland has secured the first-ever Finnish research funding from the FDA. In addition to Professor Urtti, the project, which is estimated at approximately 250 000 dollars in value, also includes the research group of Professor Clare Strachan at